Crucell and J&J to investigate RSV vaccine

Friday 25 June 2010

Crucell NV has announced the start of a project to discover a universal prophylactic vaccine against the respiratory syncytial virus (RSV), a cause of serious respiratory illnesses in infants and children. It will be working with a unit of Johnson & Johnson.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Netherlands